Complement factor I, Human, mAb MBI-1 - HM2319-100UG

The monoclonal antibody MBI-1 recognizes Complement Factor I (CFI). CFI is a protein of the complement system (serine protease) , also known as as C3b/C4f inactivator, and is a protein that is encoded by the CFI gene, located on chromosome 4.
Quantity
100 microgram
Catalog #
HM2319-100UG
390,00 €
The monoclonal antibody MBI-1 recognizes Complement Factor I (CFI). CFI is a protein of the complement system (serine protease) , also known as as C3b/C4f inactivator, and is a protein that is encoded by the CFI gene, located on chromosome 4. It regulates complement activation by cleaving cell bound or fluid phase C3b and C4b. CFI is synthesized mostly in the liver, and is initially secreted as a single 88 kDa gene product; this precursor protein is then cleaved by furin to yield the mature CFI protein, which is a disulfide-linked dimer of heavy chain residues (residue 19-335, 51 kDa) and light chain (residues 340-583, 37 kDa). Only the mature protein is active. genetic polymorphism in CFI has been observed (variants R201S, R406H, R502L). CFI deficiency leads to low levels of complement component 3 (C3) in plasma, due to unregulated activation of the complement alternative pathway, and it has been associated with recurrent bacterial infections in children; more recently, mutations in the CFI gene have been shown to be implicated in development of Haemolytic Uremic Syndrome, a renal disease also caused by unregulated complement activation. The monoclonal antibody can be used to detect CFI levels in serum, plasma.
Weitere Informationen
Datasheet URL https://www.hycultbiotech.com/wp-content/uploads/2022/06/coa-tds_hm2319-20ug.pdf
Quantity 100 µg
Quantity 100 microgram
Species Human
Alias CFI
Application Immuno assays, Western blot
Precautions For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product.
References 1.Alba-Domínguez et al. Complement factor I deficiency: a not so rare immune defect. Characterization of newmutations and the first large gene deletion Orphanet Journal of Rare Diseases 2012, 7:42 2.Broderick, L et al; Mutations of Complement Factor I and Potential Mechanisms of Neuroinflammation in Acute Hemorrhagic Leukoencephalitis J Clin Immunol (2013) 33:162–171 3.Nilssona,S et al; Complement factor I in health and disease Molecular Immunology 48 (2011) 1611–1620 4.Roversi, P et al; Structural basis for complement factor I control and its disease-associated sequence polymorphisms PNAS 2011 108:31:12839–12844
Disease Infectious diseases, Nephrology
Applications
Application: Immuno assays Western blot

Newsletter
abonnieren

15% Rabatt

erhalten